Total Payments
$43,255
2024 Payments
$6,059
Companies
12
Transactions
40
Medicare Patients
372
Medicare Billing
$71,332
Payment Breakdown by Category
Consulting$22,055 (51.0%)
Travel$10,995 (25.4%)
Other$6,708 (15.5%)
Research$2,668 (6.2%)
Food & Beverage$828.65 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $22,055 | 10 | 51.0% |
| Travel and Lodging | $10,995 | 6 | 25.4% |
| Honoraria | $3,840 | 2 | 8.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,868 | 14 | 6.6% |
| Unspecified | $2,668 | 2 | 6.2% |
| Food and Beverage | $828.65 | 6 | 1.9% |
Payments by Type
General
$40,587
38 transactions
Research
$2,668
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Chugai Pharmaceutical Co., Ltd. | $16,578 | 7 | $0 (2017) |
| CSL Behring | $5,803 | 15 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $4,601 | 3 | $0 (2023) |
| Gamida Cell Inc. | $3,962 | 3 | $0 (2024) |
| Agios Pharmaceuticals, Inc. | $3,840 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $2,400 | 1 | $0 (2022) |
| AbbVie, Inc. | $2,338 | 1 | $0 (2019) |
| KADMON PHARMACEUTICALS LLC | $1,920 | 1 | $0 (2020) |
| National Marrow Donor Program | $856.29 | 4 | $0 (2024) |
| Incyte Corporation | $550.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,059 | 7 | CSL Behring ($3,668) |
| 2023 | $6,786 | 13 | Alexion Pharmaceuticals, Inc. ($3,601) |
| 2022 | $3,340 | 5 | Novartis Pharmaceuticals Corporation ($2,400) |
| 2021 | $1,513 | 2 | Alexion Pharmaceuticals, Inc. ($1,000) |
| 2020 | $1,920 | 1 | KADMON PHARMACEUTICALS LLC ($1,920) |
| 2019 | $6,178 | 3 | Agios Pharmaceuticals, Inc. ($3,840) |
| 2017 | $17,459 | 9 | Chugai Pharmaceutical Co., Ltd. ($16,578) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $2,935.00 | General |
| 09/19/2024 | Gamida Cell Inc. | OMISIRGE (Biological) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: ONCOLOGY | ||||||
| 09/07/2024 | Gamida Cell Inc. | OMISIRGE (Biological) | Food and Beverage | In-kind items and services | $161.77 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $214.56 | General |
| 04/28/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $214.51 | General |
| 02/02/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $366.70 | General |
| 01/17/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $366.70 | General |
| 12/13/2023 | Gamida Cell Inc. | OMISIRGE (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2023 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $69.79 | General |
| 10/20/2023 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $48.85 | General |
| 10/18/2023 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $69.79 | General |
| 10/16/2023 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $238.18 | General |
| 10/06/2023 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $86.97 | General |
| 09/29/2023 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $86.97 | General |
| 09/29/2023 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $48.85 | General |
| 08/01/2023 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $173.08 | General |
| 07/21/2023 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $173.08 | General |
| 07/05/2023 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $189.04 | General |
| 02/14/2023 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,510.00 | General |
| 02/14/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $91.48 | General |
| 06/17/2022 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: ONCOLOGY | ||||||
| 04/26/2022 | Medexus Pharma, Inc. | — | Food and Beverage | In-kind items and services | $75.72 | General |
| 03/03/2022 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $255.00 | General |
| 02/15/2022 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $354.00 | General |
| 02/15/2022 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $255.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| M19-063 | AbbVie, Inc. | $2,338 | 1 |
| Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin?s Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report | SANOFI-AVENTIS U.S. LLC | $330.92 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 98 | 268 | $96,529 | $23,980 |
| 2022 | 3 | 90 | 212 | $93,538 | $17,918 |
| 2021 | 4 | 96 | 201 | $91,806 | $16,926 |
| 2020 | 4 | 88 | 180 | $83,634 | $12,507 |
Total Patients
372
Total Services
861
Medicare Billing
$71,332
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 140 | $43,700 | $12,663 | 29.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 78 | $34,158 | $7,847 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 50 | $18,671 | $3,470 | 18.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 40 | 84 | $45,474 | $8,533 | 18.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 94 | $32,900 | $7,067 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 34 | $15,164 | $2,318 | 15.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 75 | $40,650 | $8,141 | 20.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 80 | $28,000 | $5,318 | 19.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 35 | $15,610 | $2,021 | 12.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $7,546 | $1,447 | 19.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 61 | $21,350 | $4,856 | 22.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 59 | $32,122 | $4,565 | 14.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 46 | $20,516 | $2,377 | 11.6% |
| 38206 | Collection of stem cells for transplantation | Office | 2020 | 12 | 14 | $9,646 | $708.56 | 7.3% |
About Mitchell Horwitz
Mitchell Horwitz is a Hematology & Oncology healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710040589.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mitchell Horwitz has received a total of $43,255 in payments from pharmaceutical and medical device companies, with $6,059 received in 2024. These payments were reported across 40 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($22,055).
As a Medicare-enrolled provider, Horwitz has provided services to 372 Medicare beneficiaries, totaling 861 services with total Medicare billing of $71,332. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Infectious Disease
- Location Durham, NC
- Active Since 12/19/2006
- Last Updated 09/11/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1710040589
Products in Payments
- Non-Covered Product (Drug) $16,578
- OMISIRGE (Biological) $3,962
- TIBSOVO (Drug) $3,840
- PROMACTA (Drug) $2,400
- JAKAFI (Drug) $550.00
- MOZOBIL (Drug) $330.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Durham
Michael Morse, M.d, M.D
Hematology & Oncology — Payments: $2.8M
Hematology & Oncology $2.8M
Cristina Gasparetto, M.d, M.D
Hematology & Oncology — Payments: $765,745
Hematology & Oncology $765,745
Phillip Febbo, M.d, M.D
Hematology & Oncology — Payments: $751,716
Hematology & Oncology $751,716
Ivy Altomare, Md, MD
Hematology & Oncology — Payments: $369,810
Hematology & Oncology $369,810
Jeffrey Crawford, M.d, M.D
Hematology & Oncology — Payments: $273,264
Hematology & Oncology $273,264
Dr. Matthew Mckinney, M.d, M.D
Hematology & Oncology — Payments: $259,140
Hematology & Oncology $259,140